Emil Hagström

Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracy

Leosdottir, Margret; Dahlbom, Lars; Back, Maria; Wallentin, Lars et al.

Ingår i American Heart Journal, s. 149-158, 2025

• DOI för Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracy
• Ladda ner fulltext (pdf) av Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracy

Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry

Leosdottir, Margret; Schubert, Jessica; Brandts, Julia; Gustafsson, Stefan et al.

Ingår i Journal of the American College of Cardiology, s. 1550-1564, 2025

• DOI för Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
• Ladda ner fulltext (pdf) av Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry

Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden

Ögmundsdottir Michelsen, Halldora; Bäck, Maria; Ekström, Mattias; Hadziosmanovic, Nermin et al.

Ingår i BMJ Open, 2025

• DOI för Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden
• Ladda ner fulltext (pdf) av Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden

Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Gigante, Bruna; Chen, Qiaosen; Björkbacka, Harry; Björnson, Elias et al.

Ingår i International Journal of Cardiology, 2025

• DOI för Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis
• Ladda ner fulltext (pdf) av Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications

Engström, G.; Lampa, Erik; Dekkers, Koen; Lin, Yi-Ting et al.

Ingår i European Journal of Epidemiology, s. 35-49, 2024

• DOI för Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications
• Ladda ner fulltext (pdf) av Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications

Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracy

Leosdottir, Margret; Dahlbom, Lars; Back, Maria; Wallentin, Lars et al.

Ingår i American Heart Journal, s. 149-158, 2025

• DOI för Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracy
• Ladda ner fulltext (pdf) av Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracy

Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry

Leosdottir, Margret; Schubert, Jessica; Brandts, Julia; Gustafsson, Stefan et al.

Ingår i Journal of the American College of Cardiology, s. 1550-1564, 2025

• DOI för Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
• Ladda ner fulltext (pdf) av Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry

Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden

Ögmundsdottir Michelsen, Halldora; Bäck, Maria; Ekström, Mattias; Hadziosmanovic, Nermin et al.

Ingår i BMJ Open, 2025

• DOI för Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden
• Ladda ner fulltext (pdf) av Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden

Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Gigante, Bruna; Chen, Qiaosen; Björkbacka, Harry; Björnson, Elias et al.

Ingår i International Journal of Cardiology, 2025

• DOI för Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis
• Ladda ner fulltext (pdf) av Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications

Engström, G.; Lampa, Erik; Dekkers, Koen; Lin, Yi-Ting et al.

Ingår i European Journal of Epidemiology, s. 35-49, 2024

• DOI för Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications
• Ladda ner fulltext (pdf) av Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications

Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy

Wassberg, Charlotte; Batra, Gorav; Hadziosmanovic, Nermin; Hagström, Emil et al.

Ingår i European Journal of Preventive Cardiology, s. 456-465, 2024

• DOI för Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy
• Ladda ner fulltext (pdf) av Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy

Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Schubert, Jessica; Leosdottir, Margrét; Lindahl, Bertil; Westerbergh, Johan et al.

Ingår i European Heart Journal, s. 4204-4215, 2024

• DOI för Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
• Ladda ner fulltext (pdf) av Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study

Herraiz-Adillo, Angel; Ahlqvist, Viktor H.; Higueras-Fresnillo, Sara; Hedman, Kristofer et al.

Ingår i British Journal of Sports Medicine, 2024

• DOI för Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study
• Ladda ner fulltext (pdf) av Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study

Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein

Hebib, Lana; Herraiz-Adillo, Angel; Higueras-Fresnillo, Sara; Berglind, Daniel et al.

Ingår i Scientific Reports, 2024

• DOI för Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein
• Ladda ner fulltext (pdf) av Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein

Cardiac biomarkers for detection of coronary artery disease in the community

Lind, Lars; Alfredsson, Joakim; Andersson, Jonas S O; Andersson, Therese et al.

Ingår i Scientific Reports, 2024

• DOI för Cardiac biomarkers for detection of coronary artery disease in the community
• Ladda ner fulltext (pdf) av Cardiac biomarkers for detection of coronary artery disease in the community

Management and outcome in foreign-born vs native-born patients with myocardial infarction in Sweden

Zwackman, Sammy; Häggström, Jenny; Hagström, Emil; Jernberg, Tomas et al.

Ingår i European Heart Journal - Quality of Care and Clinical Outcomes, s. 507-522, 2024

• DOI för Management and outcome in foreign-born vs native-born patients with myocardial infarction in Sweden

Provision of professional interpreters and Heart School attendance for foreign-born compared with native-born myocardial infarction patients in Sweden

Zwackman, Sammy; Leosdottir, Margret; Hagström, Emil; Jernberg, Tomas et al.

Ingår i IJC Heart & Vasculature, 2024

• DOI för Provision of professional interpreters and Heart School attendance for foreign-born compared with native-born myocardial infarction patients in Sweden
• Ladda ner fulltext (pdf) av Provision of professional interpreters and Heart School attendance for foreign-born compared with native-born myocardial infarction patients in Sweden

Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage Study

Bergström, Göran; Hagberg, Eva; Björnson, Elias; Adiels, Martin et al.

Ingår i Journal of the American Heart Association, 2024

• DOI för Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage Study
• Ladda ner fulltext (pdf) av Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage Study

A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels

Svensson, Maria K.; James, Stefan; Ravn-Fischer, Annica; Villa, Guillermo et al.

Ingår i Upsala Journal of Medical Sciences, 2024

• DOI för A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels
• Ladda ner fulltext (pdf) av A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels

The effect of audit and feedback and implementation support on guideline adherence and patient outcomes in cardiac rehabilitation: a study protocol for an open-label cluster-randomized effectiveness-implementation hybrid trial

Ögmundsdóttir Michelsen, Halldóra; Lidin, Matthias; Bäck, Maria; Scott Duncan, Therese et al.

Ingår i Implementation Science, 2024

• DOI för The effect of audit and feedback and implementation support on guideline adherence and patient outcomes in cardiac rehabilitation: a study protocol for an open-label cluster-randomized effectiveness-implementation hybrid trial
• Ladda ner fulltext (pdf) av The effect of audit and feedback and implementation support on guideline adherence and patient outcomes in cardiac rehabilitation: a study protocol for an open-label cluster-randomized effectiveness-implementation hybrid trial

Cardiac rehabilitation registries around the globe: current status and future needs

Grace, Sherry L; Hagström, Emil; Harrison, Alexander S; Phillips, Samara et al.

Ingår i European Journal of Preventive Cardiology, 2024

• DOI för Cardiac rehabilitation registries around the globe: current status and future needs
• Ladda ner fulltext (pdf) av Cardiac rehabilitation registries around the globe: current status and future needs

Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals

Yari, Ali; Ueda, Peter; Lundman, Pia; Alfredsson, Joakim et al.

Ingår i European Journal of Preventive Cardiology, s. 1890-1897, 2024

• DOI för Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals
• Ladda ner fulltext (pdf) av Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals

Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population

Blomberg, Anders; Torén, Kjell; Liv, Per; Granåsen, Gabriel et al.

Ingår i Annals of the American Thoracic Society, s. 1678-1687, 2024

• DOI för Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population
• Ladda ner fulltext (pdf) av Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population

Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study

Sharad, Bashaaer; Eckerdal, Nils; Magnusson, Martin; Michelsen, Halldora Ogmundsdottir et al.

Ingår i Cardiovascular Diabetology, 2024

• DOI för Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study
• Ladda ner fulltext (pdf) av Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study

Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS

Bergstrom, Goran; Rosengren, Annika; Brolin, Elin Bacsovics; Brandberg, John et al.

Ingår i Atherosclerosis, s. 46-54, 2023

• DOI för Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS
• Ladda ner fulltext (pdf) av Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS

Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

Olszowka, Maciej; Hagström, Emil; Hadziosmanovic, Nermin; Ljunggren, Mirjam et al.

Ingår i International Journal of Cardiology, 2023

• DOI för Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome
• Ladda ner fulltext (pdf) av Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

High prevalence of interstitial lung abnormalities in middle-aged never-smokers

Pesonen, Ida; Johansson, Fredrik; Johnsson, Åse; Blomberg, Anders et al.

Ingår i ERJ Open Research, 2023

• DOI för High prevalence of interstitial lung abnormalities in middle-aged never-smokers
• Ladda ner fulltext (pdf) av High prevalence of interstitial lung abnormalities in middle-aged never-smokers

Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Lin, E.; Garmo, Hans; Hagström, Emil; Van Hemelrijck, Mieke et al.

Ingår i British Journal of Cancer, s. 814-824, 2023

• DOI för Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Prevalence of angina pectoris and association with coronary atherosclerosis in a general population

Welén Schef, Kerstin; Tornvall, Per; Alfredsson, Joakim; Hagström, Emil et al.

Ingår i Heart, s. 1450-1459, 2023

• DOI för Prevalence of angina pectoris and association with coronary atherosclerosis in a general population
• Ladda ner fulltext (pdf) av Prevalence of angina pectoris and association with coronary atherosclerosis in a general population

Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction

Schubert, Jessica; Lindahl, Bertil; Melhus, Håkan; Renlund, Henrik et al.

Ingår i Journal of Internal Medicine, s. 616-627, 2023

• DOI för Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction
• Ladda ner fulltext (pdf) av Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction

Cohort profile: Data standards for cardiac rehabilitation structure and processes for the SWEDEHEART cardiac rehabilitation (SWEDEHEART-CR) registry

Leosdottir, Margret; Back, Maria; Dahlbom, Lars; Ekstrom, Mattias et al.

Ingår i PLOS ONE, 2023

• DOI för Cohort profile: Data standards for cardiac rehabilitation structure and processes for the SWEDEHEART cardiac rehabilitation (SWEDEHEART-CR) registry
• Ladda ner fulltext (pdf) av Cohort profile: Data standards for cardiac rehabilitation structure and processes for the SWEDEHEART cardiac rehabilitation (SWEDEHEART-CR) registry

Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study

Ostgren, Carl Johan; Otten, Julia; Festin, Karin; Angeras, Oskar et al.

Ingår i Cardiovascular Diabetology, 2023

• DOI för Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study
• Ladda ner fulltext (pdf) av Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study

Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population

Cederström, Sofia; Lundman, Pia; Alfredsson, Joakim; Hagström, Emil et al.

Ingår i Scientific Reports, 2023

• DOI för Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population
• Ladda ner fulltext (pdf) av Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population

Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study

Leosdottir, Margret; Hagström, Emil; Hadziosmanovic, Nermin; Norhammar, Anna et al.

Ingår i BMJ Open, 2023

• DOI för Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study
• Ladda ner fulltext (pdf) av Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study

Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial

Ritsinger, Viveca; Hagström, Emil; Hambraeus, Kristina; James, Stefan et al.

Ingår i Journal of diabetes and its complications, 2023

• DOI för Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
• Ladda ner fulltext (pdf) av Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial

Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial

Sundström, Johan; Lind, Lars; Nowrouzi, Shamim; Hagström, Emil et al.

Ingår i Journal of the American Medical Association (JAMA), s. 1160-1160, 2023

• DOI för Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial

Reliability of the Swedish version of the multidimensional outcome expectations for exercise scale (MOEES-SW) in a cardiac population.

Urell, Charlotte; Hellström, Karin; Johansson, Henrik; Breidenskog, Marie et al.

Ingår i Physiotherapy Theory and Practice, s. 1779-1788, 2022

• DOI för Reliability of the Swedish version of the multidimensional outcome expectations for exercise scale (MOEES-SW) in a cardiac population.
• Ladda ner fulltext (pdf) av Reliability of the Swedish version of the multidimensional outcome expectations for exercise scale (MOEES-SW) in a cardiac population.

Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study

Lind, Lars; Markstad, Hanna; Ahlström, Håkan; Angerås, Oskar et al.

Ingår i Atherosclerosis, s. 1-10, 2022

• DOI för Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study
• Ladda ner fulltext (pdf) av Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström, Emil; Steg, P. Gabriel; Szarek, Michael; Bhatt, Deepak L. et al.

Ingår i Circulation, s. 657-672, 2022

• DOI för Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
• Ladda ner fulltext (pdf) av Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Cohort profile: the Swedish study of SUDden cardiac Death in the Young (SUDDY) 2000-2010: a complete nationwide cohort of SCDs

Stattin, Evalena; Hagström, Emil; Dahl, Niklas; Strömsöe, Anneli et al.

Ingår i BMJ Open, 2022

• DOI för Cohort profile: the Swedish study of SUDden cardiac Death in the Young (SUDDY) 2000-2010: a complete nationwide cohort of SCDs
• Ladda ner fulltext (pdf) av Cohort profile: the Swedish study of SUDden cardiac Death in the Young (SUDDY) 2000-2010: a complete nationwide cohort of SCDs

Family History and Warning Symptoms Precede Sudden Cardiac Death in Arrhythmogenic Right Ventricular Cardiomyopathy (From A Nationwide Study in Sweden)

Delgado-Vega, Angelica Maria; Kommata, Varvara; Svennblad, Bodil; Wisten, Aase et al.

Ingår i American Journal of Cardiology, s. 124-130, 2022

• DOI för Family History and Warning Symptoms Precede Sudden Cardiac Death in Arrhythmogenic Right Ventricular Cardiomyopathy (From A Nationwide Study in Sweden)
• Ladda ner fulltext (pdf) av Family History and Warning Symptoms Precede Sudden Cardiac Death in Arrhythmogenic Right Ventricular Cardiomyopathy (From A Nationwide Study in Sweden)

Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study

Brinck, Jonas; Hagström, Emil; Nåtman, Jonatan; Franzén, Stefan et al.

Ingår i Diabetes Care, s. 3040-3049, 2022

• DOI för Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study

Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden

Landmesser, Ulf; Lindgren, Peter; Hagström, Emil; van Hout, Ben et al.

Ingår i European Heart Journal - Quality of Care and Clinical Outcomes, s. 31-38, 2022

• DOI för Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden
• Ladda ner fulltext (pdf) av Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden

Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care

Lindell, Olof Persson; Karlsson, Lars O.; Nilsson, Staffan; Charitakis, Emmanouil et al.

Ingår i American Heart Journal, s. 132-148, 2022

• DOI för Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care
• Ladda ner fulltext (pdf) av Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care

Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Schillemans, Tessa; Tragante, Vinicius; Maitusong, Buamina; Gigante, Bruna et al.

Ingår i Frontiers in Physiology, 2022

• DOI för Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis
• Ladda ner fulltext (pdf) av Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry

Figtree, Gemma A.; Vernon, Stephen T.; Hadziosmanovic, Nermin; Sundström, Johan et al.

Ingår i Journal of the American Heart Association, 2022

• DOI för Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry
• Ladda ner fulltext (pdf) av Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

Hageman, Steven H. J.; McKay, Ailsa J.; Ueda, Peter; Gunn, Laura H. et al.

Ingår i European Heart Journal, s. 1715-1727, 2022

• DOI för Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
• Ladda ner fulltext (pdf) av Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy

Held, Claes; Hadziosmanovic, Nermin; Aylward, Philip E.; Hagström, Emil et al.

Ingår i Journal of the American Heart Association, 2022

• DOI för Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy
• Ladda ner fulltext (pdf) av Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy

Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES

Chiang, Chern-En; Schwartz, Gregory G; Elbez, Yedid; Szarek, Michael et al.

Ingår i Canadian Journal of Cardiology, s. 1542-1549, 2022

• DOI för Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES
• Ladda ner fulltext (pdf) av Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES

Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.

Cedervall, Jessica; Herre, Melanie; Dragomir, Anca; Rabelo-Melo, F et al.

Ingår i Oncoimmunology, 2022

• DOI för Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.
• Ladda ner fulltext (pdf) av Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Zethelius, Björn et al.

Ingår i JAMA Network Open, 2022

• DOI för Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
• Ladda ner fulltext (pdf) av Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Accelerometer derived physical activity patterns in 27.890 middle‐aged adults: The SCAPIS cohort study

Ekblom‐Bak, Elin; Börjesson, Mats; Bergman, Frida; Bergström, Göran et al.

Ingår i Scandinavian Journal of Medicine and Science in Sports, s. 866-880, 2022

• DOI för Accelerometer derived physical activity patterns in 27.890 middle‐aged adults: The SCAPIS cohort study
• Ladda ner fulltext (pdf) av Accelerometer derived physical activity patterns in 27.890 middle‐aged adults: The SCAPIS cohort study

Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention

Venetsanos, Dimitrios; Träff, Erik; Erlinge, David; Hagström, Emil et al.

Ingår i Heart, s. 1145-1151, 2021

• DOI för Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention
• Ladda ner fulltext (pdf) av Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention

Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Olszowka, Maciej; Held, Claes; Hadziosmanovic, Nermin; Denchev, Stefan et al.

Ingår i Journal of Internal Medicine, s. 392-403, 2021

• DOI för Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome
• Ladda ner fulltext (pdf) av Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study

Schubert, Jessica; Lindahl, Bertil; Melhus, Håkan; Renlund, Henrik et al.

Ingår i European Heart Journal, s. 243-252, 2021

• DOI för Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study
• Ladda ner fulltext (pdf) av Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study

The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)

Bäck, Maria; Leosdottir, Margret; Hagström, Emil; Norhammar, Anna et al.

Ingår i European Heart Journal - Quality of Care and Clinical Outcomes, s. 431-437, 2021

• DOI för The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)

Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.

Ritsinger, Viveca; Hagström, Emil; Lagerqvist, Bo; Norhammar, Anna

Ingår i Journal of the American Heart Association, 2021

• DOI för Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.
• Ladda ner fulltext (pdf) av Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Schwartz, Gregory G; Szarek, Michael; Bittner, Vera A; Bhatt, Deepak L et al.

Ingår i Diabetes Care, s. 1219-1227, 2021

• DOI för Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.

Schwartz, Gregory G; Szarek, Michael; Bittner, Vera A; Diaz, Rafael et al.

Ingår i Journal of the American College of Cardiology, s. 421-433, 2021

• DOI för Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.

Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up.

Littmann, Karin; Hagström, Emil; Häbel, Henrike; Bottai, Matteo et al.

Ingår i European Journal of Preventive Cardiology, s. 2038-2047, 2021

• DOI för Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up.

Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

Figtree, Gemma A.; Vernon, Stephen T.; Hadziosmanovic, Nermin; Sundström, Johan et al.

Ingår i The Lancet, s. 1085-1094, 2021

• DOI för Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17

Allahyari, Ali; Jernberg, Tomas; Lautsch, Dominik; Lundman, Pia et al.

Ingår i European Heart Journal - Quality of Care and Clinical Outcomes, s. 59-67, 2021

• DOI för Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
• Ladda ner fulltext (pdf) av Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17

Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study

Hagström, Emil; Sorio Vilela, Francesc; Svensson, Maria K.; Hallberg, Sara et al.

Ingår i Advances in Therapy, s. 4695-4708, 2021

• DOI för Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study
• Ladda ner fulltext (pdf) av Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Batra, Gorav; Ghukasyan, Tatevik; Lindbäck, Johan; Held, Claes et al.

Ingår i JAMA cardiology, s. 1440-1445, 2021

• DOI för Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population

Bergstrom, Goran; Persson, Margaretha; Adiels, Martin; Bjornson, Elias et al.

Ingår i Circulation, s. 916-929, 2021

• DOI för Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
• Ladda ner fulltext (pdf) av Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Wallentin, Lars; Eriksson, Niclas; Olszowka, Maciej; Grammer, Tanja et al.

Ingår i PLoS Medicine, 2021

• DOI för Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
• Ladda ner fulltext (pdf) av Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Coronary artery disease in the absence of traditional risk factors: a call for action

Avis, Suzanne R.; Vernon, Stephen T.; Hagström, Emil; Figtree, Gemma A.

Ingår i European Heart Journal, s. 3822-3824, 2021

• DOI för Coronary artery disease in the absence of traditional risk factors: a call for action

Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study

Velders, Matthijs A.; Hagström, Emil; James, Stefan

Ingår i Journal of the American Heart Association, 2020

• DOI för Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study
• Ladda ner fulltext (pdf) av Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study

Cardiac rehabilitation after acute myocardial infarction in Sweden: evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study

Ögmundsdottir Michelsen, Halldora; Sjölin, Ingela; Schlyter, Mona; Hagström, Emil et al.

Ingår i European Journal of Preventive Cardiology, s. 18-27, 2020

• DOI för Cardiac rehabilitation after acute myocardial infarction in Sweden: evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study

Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Mahmoodi, Bakhtawar K.; Tragante, Vinicius; Kleber, Marcus E.; Holmes, Michael V. et al.

Ingår i Circulation, s. 546-555, 2020

• DOI för Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry

Ritsinger, Viveca; Lagerqvist, Bo; Lundman, Pia; Hagström, Emil et al.

Ingår i Diabetes & Vascular Disease Research, 2020

• DOI för Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
• Ladda ner fulltext (pdf) av Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry

Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study.

Östgren, Carl J; Söderberg, Stefan; Festin, Karin; Angerås, Oskar et al.

Ingår i European Journal of Preventive Cardiology, s. 250-259, 2020

• DOI för Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study.

Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study

Allahyari, Ali; Jernberg, Tomas; Hagström, Emil; Leosdottir, Margrét et al.

Ingår i European Heart Journal, s. 3900-3909, 2020

• DOI för Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
• Ladda ner fulltext (pdf) av Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study

Weight gain and blood pressure

Sundström, Johan; Lind, Lars; Lampa, Erik; Angerås, Oskar et al.

Ingår i Journal of Hypertension, s. 387-394, 2020

• DOI för Weight gain and blood pressure

Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial

Damask, Amy; Steg, P Gabriel; Schwartz, Gregory G; Szarek, Michael et al.

Ingår i Circulation, s. 624-636, 2020

• DOI för Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

Szarek, Michael; Hagström, Emil; Zobouyan, Isabelle

Ingår i Circulation. Cardiovascular Quality and Outcomes, 2019

• DOI för Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Patel, Riyaz S.; Schmidt, Amand F.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Ingår i Circulation, 2019

• DOI för Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data
• Ladda ner fulltext (pdf) av Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Patel, Riyaz S.; Tragante, Vinicius; Schmidt, Amand F.; McCubrey, Raymond O. et al.

Ingår i Circulation, 2019

• DOI för Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium
• Ladda ner fulltext (pdf) av Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

Wallert, John; Mitchell, Adam; Held, Claes; Hagström, Emil et al.

Ingår i International Journal of Cardiology, s. 19-24, 2019

• DOI för Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study
• Ladda ner fulltext (pdf) av Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

Goodman, Shaun G.; Hagström, Emil; Ball, Eric

Ingår i Journal of the American College of Cardiology, s. 1177-1186, 2019

• DOI för Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
• Ladda ner fulltext (pdf) av Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, Kausik K.; Hagström, Emil; Zobouyan, Isabelle

Ingår i The Lancet Diabetes and Endocrinology, s. 618-628, 2019

• DOI för Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Roe, Matthew T.; Hagström, Emil; Zobouyan, Isabelle

Ingår i Circulation, s. 1578-1589, 2019

• DOI för Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
• Ladda ner fulltext (pdf) av Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

Steg, Philippe Gabriel; Hagström, Emil; Zobouyan, Isabelle

Ingår i Circulation, s. 103-112, 2019

• DOI för Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
• Ladda ner fulltext (pdf) av Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial

Jukema, J. Wouter; Hagström, Emil; Zobouyan, Isabelle

Ingår i Journal of the American College of Cardiology, s. 1167-1176, 2019

• DOI för Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial
• Ladda ner fulltext (pdf) av Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

White, Harvey D.; Hagström, Emil; Ball, Eric

Ingår i European Heart Journal, s. 2801-2809, 2019

• DOI för Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
• Ladda ner fulltext (pdf) av Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Stewart, Ralph A. H.; Held, Claes; Krug-Gourley, Sue; Waterworth, Dawn et al.

Ingår i Journal of the American Heart Association, 2019

• DOI för Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease
• Ladda ner fulltext (pdf) av Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Bhatt, Deepak L.; Fox, Kim; Harrington, Robert A.; Leiter, Lawrence A. et al.

Ingår i Clinical Cardiology, s. 498-505, 2019

• DOI för Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
• Ladda ner fulltext (pdf) av Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

Szarek, Michael; Hagström, Emil; Zobouyan, Isabelle

Ingår i Journal of the American College of Cardiology, s. 387-396, 2019

• DOI för Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
• Ladda ner fulltext (pdf) av Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial

Sharma, Abhinav; Hagström, Emil; Wojdyla, Daniel M.; Neely, Megan L. et al.

Ingår i American Heart Journal, s. 106-113, 2019

• DOI för Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial

Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)

Ridefelt, Peter; Hagström, Emil; Svensson, Maria K.; Åkerfeldt, Torbjörn et al.

Ingår i Scandinavian Journal of Clinical and Laboratory Investigation, s. 39-42, 2019

• DOI för Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)
• Ladda ner fulltext (pdf) av Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)

Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

Velders, Matthijs A.; Calais, Fredrik; Dahle, Nina; Fall, Tove et al.

Ingår i Upsala Journal of Medical Sciences, s. 187-192, 2019

• DOI för Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction
• Ladda ner fulltext (pdf) av Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Schwartz, G. G.; Hagström, Emil; Ball, Eric

Ingår i New England Journal of Medicine, s. 2097-2107, 2018

• DOI för Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Hagström, Emil; Norlund, Fredrika; Stebbins, Amanda; Armstrong, P W et al.

Ingår i Journal of Internal Medicine, s. 83-92, 2018

• DOI för Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Response to Letter: 'Sorrow and cardiovascular events'

Hagström, Emil; Held, Claes

Ingår i Journal of Internal Medicine, s. 415-415, 2018

• DOI för Response to Letter: 'Sorrow and cardiovascular events'

Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol

Larsson, Anders; Hagström, Emil; Nilsson, Lennart; Svensson, Maria K.

Ingår i Upsala Journal of Medical Sciences, s. 94-99, 2018

• DOI för Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol
• Ladda ner fulltext (pdf) av Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol

Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

Journath, Gunilla; Hambraeus, Kristina; Hagström, Emil; Pettersson, Billie et al.

Ingår i BMC Cardiovascular Disorders, 2017

• DOI för Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
• Ladda ner fulltext (pdf) av Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Lindholm, Daniel; Lindbäck, Johan; Armstrong, Paul W.; Budaj, Andrzej et al.

Ingår i Journal of the American College of Cardiology, s. 813-826, 2017

• DOI för Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

Hagström, Emil; Held, Claes; Stewart, Ralph A H; Aylward, Philip E et al.

Ingår i Clinical Chemistry, s. 325-333, 2017

• DOI för Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.

Lindholm, Daniel P; Hagström, Emil; James, Stefan K; Becker, Richard C et al.

Ingår i Journal of the American Heart Association, 2017

• DOI för Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.
• Ladda ner fulltext (pdf) av Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.

Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip

Lind, Lars; Sundström, Johan; Stenemo, Markus; Hagström, Emil et al.

Ingår i Heart, s. 379-384, 2017

• DOI för Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Guimaraes, Patricia Oliveira; Granger, Christopher B.; Stebbins, Amanda; Chiswell, Karen et al.

Ingår i Journal of the American Heart Association, 2017

• DOI för Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
• Ladda ner fulltext (pdf) av Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Vedin, Ola; Hagström, Emil; Östlund, Ollie; Avezum, Alvaro et al.

Ingår i International Journal of Cardiology, s. 271-276, 2017

• DOI för Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

Stewart, Ralph A H; Hagström, Emil; Held, Claes; Wang, Tom Kai Ming et al.

Ingår i Journal of the American Heart Association, 2017

• DOI för Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
• Ladda ner fulltext (pdf) av Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Stewart, Ralph A. H.; Held, Claes; Hadziosmanovic, Nermin; Armstrong, Paul W. et al.

Ingår i Journal of the American College of Cardiology, s. 1689-1700, 2017

• DOI för Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Zewinger, Stephen; Kleber, Marcus E.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 534-543, 2017

• DOI för Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Comparison Of Methods To Measure Patient Adherence And Persistence With Pharmacological Therapy: A Systematic Review

Forbes, C. A.; Deshpande, S.; Sorio-Vilela, F.; Kutikova, L. et al.

Ingår i Value in Health, 2017

Equal clinical performance of a novel point-of-care cardiac troponin I (cTnI) assay with a commonly used high-sensitivity cTnI assay

Venge, Per; van Lippen, Lian; Blaschke, Sabine; Christ, Michael et al.

Ingår i Clinica Chimica Acta, s. 119-125, 2017

• DOI för Equal clinical performance of a novel point-of-care cardiac troponin I (cTnI) assay with a commonly used high-sensitivity cTnI assay
• Ladda ner fulltext (pdf) av Equal clinical performance of a novel point-of-care cardiac troponin I (cTnI) assay with a commonly used high-sensitivity cTnI assay

Tooth Loss is Independently Associated with Poor Outcomes in Stable Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Budaj, Andrzej; Denchev, Stephan et al.

Ingår i European Journal of Preventive Cardiology, s. 839-846, 2016

• DOI för Tooth Loss is Independently Associated with Poor Outcomes in Stable Coronary Heart Disease

The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

Rerup, Sofie Aagaard; Bang, Lia E.; Mogensen, Ulrik M.; Engstrøm, Thomas et al.

Ingår i American Heart Journal, s. 35-42, 2016

• DOI för The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

Self-Reported General Health And Outcomes In Patients With Stable Coronary Artery Disease: Experiences From The Global Stability Trial

Stewart, Ralph Alan Huston; Hagström, Emil; Held, Claes; Armstrong, Paul et al.

Ingår i Journal of the American College of Cardiology, s. 2113-2113, 2016

The Relationship Between Tooth Loss, Cardiovascular Biomarkers And Outcomes In Patients With Stable Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Östlund, Ollie; Avezum, Alvaro et al.

Ingår i Journal of the American College of Cardiology, s. 1969-1969, 2016

Diabetes Mellitus And Cardiovascular Risk In Patients With Chronic Coronary Heart Disease

Sinnaeve, Peter R.; Hagström, Emil; Armstrong, Paul; Budaj, Andrzej et al.

Ingår i Journal of the American College of Cardiology, s. 2162-2162, 2016

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

Hagström, Emil; James, Stefan; Bertilsson, Maria; Becker, Richard C et al.

Ingår i European Heart Journal, s. 1325-1333, 2016

• DOI för Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

Stewart, Ralph A. H.; Wallentin, Lars; Benatar, Jocelyne; Danchin, Nicolas et al.

Ingår i European Heart Journal, s. 1993-2001, 2016

• DOI för Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
• Ladda ner fulltext (pdf) av Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Wallentin, Lars; Held, Claes; Armstrong, Paul W.; Cannon, Christopher P. et al.

Ingår i Journal of the American Heart Association, 2016

• DOI för Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

Rerup, S. N. A. A.; Bang, L. E.; Mogensen, U. M.; Engstroem, T. et al.

Ingår i EUROPEAN HEART JOURNAL, s. 141-141, 2016

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

Hagström, Emil; Roe, Matthew T.; Hafley, Gail; Neely, Megan L. et al.

Ingår i Clinical Cardiology, s. 329-337, 2016

• DOI för Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort

Hagström, Emil; Ahlström, Tommy; Ärnlöv, Johan; Larsson, Anders et al.

Ingår i Atherosclerosis, s. 420-426, 2015

• DOI för Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort

Tooth Loss Is Independently Associated With Adverse Outcome But Not Myocardial Infarction In Patients With Chronic Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Budaj, Andrzej; Denchev, Stephan et al.

Ingår i Journal of the American College of Cardiology, 2015

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO)

Johansson, Åsa; Eriksson, Niclas; Becker, Richard C.; Storey, Robert F. et al.

Ingår i Circulation, s. 498-506, 2015

• DOI för NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO)

Management and clinical consequences of major bleeding in high-risk patients following an acute coronary syndrome. Is aspirin the problem?: Insights from the APPRAISE-2 trial

Hagström, Emil; Wojdyla, D.; Neely, M. L.; Stevens, S. R. et al.

Ingår i European Heart Journal, s. 861-862, 2015

Effect of ivabradine on heart rate variability in patients with stable coronary artery disease

Stewart, R. A. H.; Armstrong, P. W.; Chiswell, K.; Hagström, Emil et al.

Ingår i European Heart Journal, s. 1088-1088, 2015

Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention

Hess, Connie N.; Roe, Matthew T.; Clare, Robert M.; Chiswell, Karen et al.

Ingår i Journal of the American Heart Association, 2015

• DOI för Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Varenhorst, Christoph; Eriksson, Niclas; Johansson, Åsa; Barratt, Bryan J. et al.

Ingår i European Heart Journal, s. 1901-1912, 2015

• DOI för Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes Insights From the APPRAISE-2 Trial

Hess, Connie N.; James, Stefan K.; Lopes, Renato D.; Wojdyla, Daniel M. et al.

Ingår i Journal of the American College of Cardiology, s. 777-787, 2015

• DOI för Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes Insights From the APPRAISE-2 Trial

Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

Vedin, Ola; Hagström, Emil; Gallup, Dianne; Neely, Megan L et al.

Ingår i European Journal of Preventive Cardiology, s. 771-778, 2015

• DOI för Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

ApoA1 is independently associated with recurrent ischemic events and death in acute coronary syndrome patients

Oskarsson, A.; Varenhorst, Christoph; Hagström, Emil; Wernroth, Mona-Lisa et al.

Ingår i European Heart Journal, s. 482-482, 2014

Plasma-Parathyroid Hormone Is Associated With Subclinical and Clinical Atherosclerotic Disease in 2 Community-Based Cohorts

Hagström, Emil; Michaëlsson, Karl; Melhus, Håkan; Hansen, Tomas et al.

Ingår i Arteriosclerosis, Thrombosis and Vascular Biology, s. 1567-73, 2014

• DOI för Plasma-Parathyroid Hormone Is Associated With Subclinical and Clinical Atherosclerotic Disease in 2 Community-Based Cohorts

Plasma Parathyroid Hormone Is Associated with Vascular Dementia and Cerebral Hyperintensities in Two Community-Based Cohorts

Hagström, Emil; Kilander, Lena; Nylander, Ruta; Larsson, Elna-Marie et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, s. 4181-4189, 2014

• DOI för Plasma Parathyroid Hormone Is Associated with Vascular Dementia and Cerebral Hyperintensities in Two Community-Based Cohorts

Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study

Vimaleswaran, Karani S; Cavadino, Alana; Berry, Diane J; Jorde, Rolf et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 719-729, 2014

• DOI för Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study
• Ladda ner fulltext (pdf) av Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

Vedin, Ola; Hagström, Emil; Stewart, Ralph; Brown, Rebekkah et al.

Ingår i European Journal of Preventive Cardiology, s. 678-685, 2013

• DOI för Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

Tooth loss is highly prevalent and associated with cardiovascular risk factors in patients with chronic coronary heart disease in the global stability trial

Vedin, Ola; Hagström, Emil; Gallup, Dianne; Neely, Megan et al.

Ingår i Journal of the American College of Cardiology, 2013

• DOI för Tooth loss is highly prevalent and associated with cardiovascular risk factors in patients with chronic coronary heart disease in the global stability trial

Physical activity in patients with stable coronary heart disease: an international perspective

Stewart, Ralph; Held, Claes; Brown, Rebekkah; Vedin, Ola et al.

Ingår i European Heart Journal, s. 3286-3293, 2013

• DOI för Physical activity in patients with stable coronary heart disease: an international perspective

»HEART score« – lösningen på säker handläggning av patienter med misstänkt akut kranskärlsjukdom på akutmottagningen?: ["HEART score"--the solution for secure management of patients with suspected acute coronary syndrome in the emergency department?]

Alsén, Martin; Hagström, Emil; Eggers, Kai; Johnston, Nina

Ingår i Läkartidningen, s. 1297, 2013

Are There Any Causal Relations Between Growth Differentiation Factor 15 and Outcomes in Patients With Acute Coronary Syndrome?: - A Report From the Plato Gwas Study

Hagström, Emil; Eriksson, Niclas; Johansson, Åsa; Bertilsson, Maria et al.

Ingår i Circulation, 2013

Evaluation of the Effect of Interleukin 18 Associated Genetic Polymorphisms on Risk of Cardiovascular Events in Patients With Acute Coronary Syndrome

Siegbahn, Agneta; Johansson, Åsa; Eriksson, Niclas; Hagström, Emil et al.

Ingår i Circulation, 2013

Plasma parathyroid hormone and the risk of cerebrovascular diseases in the community

Hagström, Emil; Ärnlöv, Johan; Kilander, Lena

Ingår i European Heart Journal, s. 236-236, 2012

• DOI för Plasma parathyroid hormone and the risk of cerebrovascular diseases in the community

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes

Levin, G. P.; Robinson-Cohen, C.; De Boer, I. H.; Houston, D. K. et al.

Ingår i Journal of the American Medical Association (JAMA), s. 1898-1905, 2012

• DOI för Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes

Livshotande hjärtsvikt av ADHD-medicinering: Fem patientfall beskrivs

Wikström, Gerhard; Kvidal, Per; Hagström, Emil

Ingår i Läkartidningen, s. 2016-2018, 2012

Plasma parathyroid hormone and risk of congestive heart failure in the community

Hagström, Emil; Ingelsson, Erik; Sundström, Johan; Hellman, Per et al.

Ingår i European Journal of Heart Failure, s. 1186-1192, 2010

• DOI för Plasma parathyroid hormone and risk of congestive heart failure in the community

Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community

Larsson, Tobias E; Olauson, Hannes; Hagström, Emil; Ingelsson, Erik et al.

Ingår i Arteriosclerosis, Thrombosis and Vascular Biology, s. 333-339, 2010

• DOI för Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Hagström, Emil; Hellman, Per; Larsson, Tobias E.; Ingelsson, Erik et al.

Ingår i Circulation, s. 2765-2771, 2009

• DOI för Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women

Ahlström, Tommy; Hagström, Emil; Larsson, Anders; Rudberg, Claes et al.

Ingår i Clinical Endocrinology, s. 673-678, 2009

• DOI för Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women

Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort

Hagström, Emil; Hellman, Per; Lundgren, Ewa; Lind, Lars et al.

Ingår i Diabetologia, s. 317-324, 2007

• DOI för Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort

Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening

Hagström, Emil; Lundgren, Ewa; Rastad, Jonas; Hellman, Per

Ingår i European Journal of Endocrinology, s. 33-39, 2006

• DOI för Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening

Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism

Hagström, Emil; Lundgren, Ewa; Mallmin, Hans; Rastad, Jonas et al.

Ingår i Journal of Internal Medicine, s. 191-198, 2006

Primary hyperparathyroidism revisited in menopausal women with serum calcium in upper normal range at population-based screening 8 years ago

Lundgren, Ewa; Hagström, Emil; Lundin, Jonas; Winnerbäck, Kajsa et al.

Ingår i World Journal of Surgery, s. 931-936, 2002

• DOI för Primary hyperparathyroidism revisited in menopausal women with serum calcium in upper normal range at population-based screening 8 years ago

Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years

Hagström, Emil; Lundgren, Ewa; Lithell, Hans; Berglund, Lars et al.

Ingår i Clinical Endocrinology (Oxf), s. 253-260, 2002

Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review

Figtree, Gemma A.; Vernon, Stephen T.; Harmer, Jason A.; Gray, Michael P. et al.

Ingår i Journal of the American College of Cardiology, s. 1343-1359, 2023

• DOI för Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
• Ladda ner fulltext (pdf) av Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review

E78.0A – en unik, ny ICD-10-kod för familjär hyperkolesterolemi: [Sweden introduces a new specific ICD-10 code for the disease familial hypercholesterolemia]

Brinck, Jonas; Hagström, Emil; Benedek, Peter; Hedelin, Rikard et al.

Ingår i Läkartidningen, 2019

A systematic literature review comparing methods for the measurement of patient persistence and adherence

Forbes, Carol A.; Deshpande, Sohan; Sorio-Vilela, Francesc; Kutikova, Lucie et al.

Ingår i Current Medical Research and Opinion, s. 1613-1625, 2018

• DOI för A systematic literature review comparing methods for the measurement of patient persistence and adherence

Low-renin hypertension

Hellman, Per; Hagström, Emil

Ingår i Primary aldosteronism, s. 39-44, Springer, 2014

Living alone and depressive symptoms are associated with major cardiovascular events in patients with chronic coronary heart disease

Hagström, Emil; Norlund, Fredrika; Harrington, R. A.; Lopez-Sendon, J. et al.

s. 1144-1144, 2015

Primary Hyperparathyroidism is associated with low insulin sensitivity and impaired glucose metabolism

Hagström, Emil; Lundgren, Ewa; Hellman, Per